Measles Virus and Subacute Sclerosing Panencephalitis

Clinical Laboratory
|September 20, 2022
PubMed
Abstract

Insights

Measles virus is linked to Subacute Sclerosing Panencephalitis (SSPE), a severe neurological disease. Laboratory tests confirmed measles IgG antibodies in the cerebrospinal fluid of SSPE patients, highlighting the need for diagnostic confirmation.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Background:

  • Subacute Sclerosing Panencephalitis (SSPE) is a rare, progressive neurological disorder primarily affecting children and young adults.
  • It is a chronic inflammatory condition of the brain, often developing years after an initial measles virus infection.
  • Measles virus is the most common cause, though rubella virus has been implicated in rare cases.

Purpose of the Study:

  • To investigate the laboratory role of measles virus in the development of neurological symptoms and central nervous system (CNS) diseases.
  • To analyze clinical materials from patients diagnosed with SSPE and encephalitis.

Main Methods:

  • Serological testing (indirect ELISA) for measles IgG and IgM antibodies in serum and cerebrospinal fluid (CSF).
  • Molecular analysis using RT-PCR to detect viral RNA.
  • Testing of 46 clinical samples (23 sera, 23 CSF) from 23 patients.

Main Results:

  • Measles IgG antibodies were detected in sera of 21 patients.
  • Measles IgG antibodies were found in the CSF of four SSPE patients, with high antibody titers.
  • All SSPE patients with positive CSF results had a history of measles infection before age two; no viral RNA was detected by RT-PCR.

Conclusions:

  • Measles infection can lead to severe CNS complications across all age groups.
  • SSPE diagnosis is challenging, underscoring the importance of laboratory confirmation for disease surveillance.
  • The study reinforces the link between measles infection and SSPE development.